A coding non-synonymous polymorphism of SLC30A8 (R325W; rs13266634) has been demonstrated to be protective for type 2 diabetes [32], [42]–[45] and was shown to influence insulin secretion following an intravenous glucose challenge [7]. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.